Director, Global Oncology Marketing - Prostate Cancer
MSD
Summary
Exciting leadership opportunity on a critical new oncology asset in late stage development for metastatic prostate cancer. The Director will be the HCP strategy and launch lead. This role will require strong team leadership capabilities, solid brand and launch strategy experience, as well as launch preparation experience. Role focuses on the overall brand strategy and the launch strategy for lead prostate indications with close coordination with relevant cross functional and geographic counterparts.
Job description
Primary Responsibilities
- Lead cross functional team in the development of HCP launch strategy for a brand new oncology asset, first launch indications in metastatic Prostate Cancer with blockbuster potential
- Working with key cross functional partners, leveraging deep insights and analytics, develop and deploy product positioning, clear differentiation strategies and brand promotion messaging
- Effectively collaborate with promotional agency partners and medical, legal, regulatory partners in development and implementation of new asset strategy
- Global launch planning lead, responsible for ensuring large cross functional team on track with launch planning deliverables
- Lead on global forecast development for new asset; develop global guidance for market forecasts
- Collaborate with leaders in key markets and regions and other key stakeholders to ensure a unified strategy that optimizes product value
Required Qualifications
- Bachelor's degree (B.S. or B.A.)
- Minimum of 8 years of progressive experience across marketing, market access or related experiences in pharmaceutical or biotechnology industries
- Experience developing product strategy in oncology
- Experience leading cross-functional teams
- Proven ability to analyze complex data and create clear long-term customer centric strategies
- Influence: Ability to clearly articulate messages/information across the enterprise, to all levels of leadership
- Strong collaborator, deep experience working within a matrixed environment and experience in stakeholder management
- Financial acumen, comfort level with forecasting
- Works effectively in fast paced and time-constrained situations. Proven ability to drive execution.
Preferred Experience and Skills
- Advanced degree (MBA)
- Strategy development experience in oncology
- Recent product launch experience
- Global marketing experience
Requirements
- Bachelor's degree (B.S. or B.A.)
- Minimum of 8 years of progressive experience across marketing, market access or related experiences in pharmaceutical or biotechnology industries
- Experience developing product strategy in oncology
- Experience leading cross-functional teams
- Proven ability to analyze complex data and create clear long-term customer centric strategies
- Ability to clearly articulate messages/information across the enterprise, to all levels of leadership
- Strong collaborator, deep experience working within a matrixed environment and experience in stakeholder management
- Financial acumen, comfort level with forecasting
- Works effectively in fast paced and time-constrained situations. Proven ability to drive execution.
- Advanced degree (MBA) preferred
- Strategy development experience in oncology preferred
- Recent product launch experience preferred
- Global marketing experience preferred
Benefits
- Medical, Dental & Vision
- Retirement benefits
- 401(k)
- Paid holidays
- Vacation
- Compassionate leave
- Sick days
- Annual bonus
- Long-term incentive
Company overview
MSD, known as Merck Sharp & Dohme outside the United States and Canada, is a global research-intensive biopharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891, the company has established itself as one of the world's leading pharmaceutical corporations with a rich history spanning over 130 years. MSD operates as the international division of Merck & Co., Inc., focusing on the discovery, development, manufacturing, and marketing of innovative medicines, vaccines, biologic therapies, and animal health products. The company's extensive portfolio includes groundbreaking treatments in oncology, infectious diseases, cardiology, diabetes, and vaccines, with notable products such as Keytruda (pembrolizumab) for cancer immunotherapy, Gardasil for HPV prevention, and Januvia for diabetes management. MSD maintains a strong commitment to research and development, investing significantly in scientific innovation to address unmet medical needs worldwide. With approximately 75,000 employees globally, the company operates through four main segments: pharmaceuticals, animal health, healthcare services, and strategic alliances. MSD's mission centers on using leading-edge science to save and improve lives around the world, guided by the principle that medicine is for people, not profits.